Bizarre Patents
Decorative Jeweled Wheel Cover
An improved wheel is provided wherein decorative items such as gem stones are embedded in either the wheel surface, a special mounting section attached to the wheel surface, or to a spoke strap that wraps around each spoke and positions embedded gem stones on the outside surface of the spoke.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7354574 | Treatment of ocular disease A method and article to treat ocular disease with Cyclosporin A alone or with compounds related to Cyclosporin A for intraocular injection or implantation. Treatment does not result in ocular toxicity and encompasses age related macular degeneration, retinitis pigme... | 04/08/2008 |
| 7332470 | Methods and compositions for treating ocular disease The use of collectins and/or surfactant proteins for the treatment and prevention of ocular disease. ... | 02/19/2008 |
| 7087249 | Treatment of mucosal membranes The invention relates to the use of one or more antimicrobial metals preferably selected from silver, gold, platinum, and palladium but most preferably silver, formed with atomic disorder, and preferably in a nanocrystalline form, for reducing inflammation or infect... | 08/08/2006 |
| 6958359 | Vanadium compounds as anti-angiogenic agents Vanadium compounds for inhibiting angiogenesis useful for treating or preventing diabetic retinopathy, hemangiomas, cancers with abnormal blood vessel supply, restenosis following vascular injury, and the like. ... | 10/25/2005 |
| 6699492 | Quinolone carboxylic acid compositions and related methods of treatment The present invention relates to the use of quinolone carboxylic acid formulations in the treatment of ocular and periocular infections. The present invention also relates to sustained release compositions comprising specific quinolone carboxylic acid com... | 03/02/2004 |
| 6685958 | Quinolone carboxylic acid compositions and related methods of treatment The present invention relates to the use of quinolone carboxylic acid formulations in the treatment of ocular and periocular infections. The present invention also relates to sustained release compositions comprising specific quinolone carboxylic acid com... | 02/03/2004 |
| 6645978 | Lipoxin A4 and its analogs for the treatment of dry eye Ophthalmic compositions containing Lipoxin A4 and its analogs and methods of their use for treating dry eve are disclosed.... | 11/11/2003 |
| 6589550 | Methods of producing intraocular lenses and materials suitable for their production A method for producing an intraocular lens, comprising the steps of injecting a high-refractive index, low viscosity composition of crosslinkable units into an enclosure and initiating polymerization under pressure to create a synthetic polymer lens. The ... | 07/08/2003 |
| 6488938 | Polylactic acid scleral plug A scleral plug which releases a drug accurately in a specified amount. The scleral plug is formed from a blend of a high-molecular weight polylactic acid having a molecular weight of 40,000 or higher and a low-molecular weight polylactic acid having a mol... | 12/03/2002 |
| 6379692 | Pharmaceutical composition comprising a suspension for the active ingredient A pharmaceutical formulation may be prepared by a method comprising providing the active ingredient in solution in a pharmacologically-acceptable base and mixing the resulting solution with a pharmacologically-acceptable acid in an amount such that the fo... | 04/30/2002 |
| 5980928 | Implant for preventing conjunctivitis in cattle A method to reduce the likelihood of conjunctivitis in farm animals, especially cattle, includes the step of injecting an implant containing an antibiotic effective against the microbes associated with conjunctivitis subcutaneously into the animal in clos... | 11/09/1999 |
| 5968824 | Agents for inducing apoptosis and applications of said agents in therapy Agents which modulate pathways of apoptotic induction or repression in which products of opioid peptide precursors genes participate, useful as inducers of apoptosis in cells and in tumor cells in particular, are disclosed. Methods of treatment employing ... | 10/19/1999 |
| 5681825 | Surgical method Methods of facilitating surgical operations that involve the eye or eye area comprise introducing an opthalmologically acceptable composition containing hyaluronic acid into the site of the surgical operation. The hyaluronic acid comprises a chemically un... | 10/28/1997 |
| 5653972 | Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds Disclosed are storage-stable preserved ophthalmic compositions containing acidic drugs in combination with polymeric quaternary ammonium compounds and boric acid.... | 08/05/1997 |
| 5603929 | Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds Disclosed are storage-stable preserved ophthalmic compositions containing acidic drugs in combination with polymeric quaternary ammonium compounds and boric acid.... | 02/18/1997 |
| 5518732 | Bio-erodible ophthalmic shield Bio-erodible ophthalmic shields comprising gelatin, a glycosaminoglycan (for example chondroitin sulfate) and carboxymethyl cellulose, and a method of treating a traumatized or "dry" eye by administering the gelatin-based ophthalmic shields to the traumat... | 05/21/1996 |
| 5501856 | Controlled-release pharmaceutical preparation for intra-ocular implant Presented are a controlled-release pharmaceutical preparation for intra-ocular implant to be applied to the interior of the eye after a surgical operation for disorders in retina/vitreous body or for glaucoma, which is produced by homogeneously dispersing... | 03/26/1996 |
| 5422116 | Liquid ophthalmic sustained release delivery system Disclosed is a sustained release liquid aqueous ophthalmic delivery system and a method of providing a slow and sustained release of ophthalmic treating agents to the eye of a mammal which comprises administering to the eye of a said mammal an effective a... | 06/06/1995 |
| 5401508 | Hydrogel compositions and structures made from same A hydrogel composition is disclosed which comprises water and a copolymer. In one embodiment, the copolymer is formed by reacting about 85% to about 99% by weight of at least one member selected from the group consisting of N,N-dimethylacrylamide, N,N-die... | 03/28/1995 |
| 5206008 | Enhancement of immune response The present invention provides an improved means for regulating the immune response, for ameliorating effects of stress, and for avoiding untoward effects of chemotherapy or exposure to irradiation by administration of androstenediol (AED) and androstenet... | 04/27/1993 |
| 5192535 | Ophthalmic suspensions Lightly crosslinked polymers, preferably ones prepared by suspension or emulsion polymerizing at least about 90% by weight of a carboxyl-containing monoethylenically unsaturated monomer such as acrylic acid with from about 0.1% to about 5% by weight of a ... | 03/09/1993 |
| 5188826 | Topical ophthalmic suspensions A topical, aqueous ophthalmic gel suspension for dry eye is administrable to the eye in drop form, remains as a gel in the eye for a prolonged time, and releases water and one or more ophthalmic demulcents or vasoconstrictors. It comprises water and from ... | 02/23/1993 |
| 5093127 | Preparation of FR115224 substrate for parenteral administration A cyclic peptide designated FR115224, administered parenterally in a cyclodextrin carrier, which exhibits antiallergic activity.... | 03/03/1992 |
| 4973466 | Wound-healing dressings and methods Wound healing dressings are prepared by flocculating fibronectin, a biologically active fragment or an analog thereof to produce a water-swellable gel. The gels, in the form of sheets, strips, wedges, strands or I-shaped cross-sections, are especially use... | 11/27/1990 |
| 4923693 | Ultraviolet radiation screening method for eyes An inventive method for preventing ultraviolet radiation exposure to the outer tissues of mammalian eyes is disclosed. In particular, the composition containing about 0.3%-0.4% hydroxypropylmethylcellulose in the form of either an eyedrop solution or an o... | 05/08/1990 |
| 4771036 | Method and ophthalmic composition for the prevention and reversal of cataracts The subject invention concerns a process for the prevention and reversal of cataracts. Specifically, the invention comprises the treatment of the eye lens with an effective cataract inhibiting amount of thioredoxin or thioredoxin-derived, or thioredoxin-l... | 09/13/1988 |
| 4716224 | Crosslinked hyaluronic acid and its use Crosslinked hyaluronic acid or salts thereof prepared by crosslinking hyaluronic acid or salts thereof with a polyfunctional epoxy compound wherein a crosslinking index or number is 5 or more per 1000 repeating disaccharides composed of glucronic acid in ... | 12/29/1987 |
| 4713244 | Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent A sustained-release polymeric hydrogel dosage form useful for topical, systemic or transdermal administration of a medicinal agent comprising a cross-linked, polymerized hydrophilic polymer, an amino acid polymer, a cross-linking agent, and an optional hy... | 12/15/1987 |
| 4668506 | Sustained-release formulation containing and amino acid polymer A sustained-release polymeric hydrogel dosage form useful for topical, systemic or transdermal administration of a medicinal agent comprising a cross-linked, polymerized hydrophilic polymer, an amino acid polymer, a cross-linking agent, an optional hydrop... | 05/26/1987 |
| 4454148 | 5-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure 5-Hydroxy-2-benzothiazolesulfonamide is useful for the topical treatment of elevated intraocular pressure. Ophthalmic compositions including drops and inserts are disclosed.... | 06/12/1984 |
